Akay Natural Ingredients study: Low-dose chili extract effective in weight management

The randomized, double-blind, placebo-controlled study, published in the journal Frontiers in Nutrition, ​investigated the efficacy of the Indian ingredients supplier’s patented extract (CapF) on energy expenditure, fat oxidation and endurance in 105 healthy overweight participants. 

CapF is red chili extract encapsulated in fenugreek soluble dietary fibre for sustained-intestinal release formulated via the company’s trademarked technology, Fenumat.

The supplement was previously found​ to be bioavailable and safe at dosages of 200 mg/day in individuals with obesity and helped to reduce body weight following 28 days of supplementation.

In the current study, participants received either placebo, CapF 100 mg/day or CapF 200 mg/day for 28 days, with results showing that CapF was efficacious at increasing both doses in energy expenditure and physical performance.

“The significance of the study comes from the observation that CapF at the tested dose was tolerated and did not produce adverse events such as increased heart rate, pulse rate, palpitation, sweating and abdominal pain, despite its efficacy,” wrote the authors from India and the United States, including two researchers from Akay. 

They found that while better results correlated with higher dosages, the lower dose could still offer a side-effect-free solution for weight management.